Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Fatih Olmez"'
Autor:
Goktas Aydin, Sabin, Bilici, Ahmet, Calis, Elif, Kutlu, Yasin, Hamdard, Jamshid, Muglu, Harun, Fatih Olmez, Omer, Karci, Ebru, Acikgoz, Ozgur
Publikováno v:
In International Immunopharmacology November 2023 124 Part B
Autor:
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Cakar, Abdallah T. M. Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gumus, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Publikováno v:
Acta Oncologica. 62:381-390
Publikováno v:
Molecular Biology Reports. 50:3489-3492
Autor:
Burcu Tunay, Omer Fatih Olmez, Ahmet Bilici, Ayberk Bayramgil, Gunes Dorukhan Cavusoglu, Huseyin Oz
Publikováno v:
Journal of Surgery and Medicine. 7:6-10
Background/Aim: Breast cancer is the second most common cause of cancer-related death in women worldwide. Predicting the prognosis in breast cancer with very high mortality is important in terms of disease treatment and increasing life expectancy. In
Autor:
Muhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, Efnan Algın, Burcu Gulbagcı, Ilhan Hacibekiroglu, Jamshid Hamdard, Omer Fatih Olmez, Hadi Akkus, Berna Oksuzoglu, Sema Sezgin Goksu, Shute Ailia Dae, Ahmet Taner Sumbul, Muzaffer Ugraklı, Mustafa Karaagac, Elif Sahin, Devrim Cabuk, Ozden Ozer, Tugba Yavuzsen, Rukiye Arıkan, Osman Köstek, Muhammed Mustafa Atcı, Abdullah Sakin, Adem Deligonul, Duygu Bayır, Murat Dincer, Oktay Unsal, Ozan Yazıcı, Esra Zeynelgil, Ahmet Gulmez, Hakan Harputluoglu, Cihan Erol, Mehmet Ali Nahit Sendur, Aydin Aytekin, Baran Akagunduz, Irem Oner, Ozlem Er, Bugra Oztosun, Mahmut Gumus, Fatih Selcuk Biricik, Musa Baris Aykan, Nuri Karadurmus, Ezgi Degerli, Nebi Serkan Demirci, Esma Turkmen, Teoman Şakalar, Saban Secmeler, Ozgur Tanrıverdi, Ali Alkan, Yasemin Kemal, Ibrahim Cil, Caglar Unal, Yakup Iriagaç, Ozkan Alan, Sevinc Balli, Yuksel Urun, Erkan Ozcan, Nazım Serdar Turhal, Irfan Cicin
Publikováno v:
Head & Neck.
Background: Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data. Methods: A total of 37 medica
Autor:
Deniz Tural, Cagatay Arslan, Fatih Selcukbiricik, Omer Fatih Olmez, Emre Akar, Mustafa Erman, Yüksel Ürün, Dilek Erdem, Nuri Karadurmus, Saadettin Kilickap
This 5-year analysis of real-world data confirms the durable response and long-term survival with ICTs in a broader range of patients with metastatic urothelial carcinoma. After 24 months, PFS and OS curves remained nearly flat. The safety profile wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8485e29d30f33b7a367a23c94a9c85a7
https://hdl.handle.net/20.500.12511/11178
https://hdl.handle.net/20.500.12511/11178
Autor:
Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici, Atakan Topcu, Musa Barış Aykan, Seda Kahraman, Ilgın Akbıyık, Muhammed Mustafa Atci, Omer Fatih Olmez, Arzu Yaren, Mehmet Ali Nahit Sendur, Caglayan Geredeli, Mesut Seker, Yuksel Urun, Nuri Karadurmus, Ahmet Aydin
Publikováno v:
Current medical research and opinion. 38(10)
Objectives: Advanced-stage biliary tract cancers (BTC) are rare malignancies with poor prognosis. There are few prospective trials, but several retrospective studies regarding treatment options. In this study, we aimed to investigate the role of syst
Publikováno v:
Journal of Statistical Computation and Simulation. 91:1524-1563
We develop a variation of a Kolmogorov-Smirnov (KS) method for estimating a power law region, including its lower and upper bounds, of the probability density in a set of data which can be modelled...
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Göktaş Aydın, Ali Gökyer, Ahmet Küçükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karataş, Hacer Demir, Ayse Irem Yasin, Adem Deligönül, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gulhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Renal cell carcinoma is the fourteenth most common cancer in the world with a male to female ratio of 2:1, and clear cell renal cell carcinoma (ccRCC) is the most common histological subtype. Nivolumab is preferred as subsequent therapy in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5a15870b5d76209b99a5b795b3e4bc
https://doi.org/10.21203/rs.3.rs-1693977/v1
https://doi.org/10.21203/rs.3.rs-1693977/v1
Autor:
Deniz Tural, Cagatay Arslan, Fatih Selcukbiricik, Omer Fatih Olmez, Mustafa Erman, Yüksel Ürün, Nuri Karadurmus, Emre Akar, Saadettin Kilickap
474 Background: Anti-tumor activity and manageable safety profile of immune checkpoint blockade therapies (ICT) have been demonstrated in previous clinical trials in patients with metastatic urothelial carcinoma. To the best of our knowledge, very li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26dc21e7da2e7871260bfc6595b9ec98
https://hdl.handle.net/20.500.12511/9349
https://hdl.handle.net/20.500.12511/9349